Defibrillator Market: By Product type (Implantable Cardioverter Defibrillators (Single Chamber Implantable Cardioverter Defibrillator, Dual Chamber Implantable Cardioverter Defibrillator), External Defibrillator (Manual, Automated, Wearable), By End-user (Hospitals, Cardiac Clinics, Home Care, Others), and Geography.  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Defibrillators Market size was valued at USD 9.8 billion in 2022 and is expected to reach USD 12.8 billion by 2029, at a CAGR of 3.8% from 2023-2029. Heart muscles require a continuous supply of blood for proper functioning. When the supply of blood to the artery is decreased cardiac arrhythmias and heart attack may occur. Blockage of the coronary artery may occur due to improper impulse conduction or blood clots. If not treated immediately may lead to death.  A defibrillator is used to prevent the sudden cardiac attack. Specially used for ventricular fibrillation and nonperfusing ventricular tachycardia. These conditions occur due to the disruption of normal electrical impulse that controls the heart rate and pumping action. The defibrillator sends an electrical current to the heart which is used to restart the normal functioning of the heart. Defibrillator treatment is given for patients only when there is a high risk of sudden heart failure or sudden cardiac death. Normally Defibrillators are used for outpatient. Many of heart care associations and alliances are promoting to create awareness about cardiac conditions and increase the survival rate of patients are expected to show significant growth for the defibrillator market during the forecast period. For instance, in 2016, the Global Resuscitation Alliance (GRA) was formed comprising of, global resuscitation leaders, international health organizations, and American Heart Association (AHA). The defibrillator market is very dynamic in nature. The defibrillator market is dominated by very few players. To enhance their sales revenue companies are inorganic growth strategies such as adopting mergers and acquisitions. In addition, companies are betting heavily on R&D to develop new technologies.

Defibrillators Market Key Developments:

  • In July 2016, Life-Assist, Inc. Partnered with Koninklijke Philips N.V. to distribute its automated external defibrillators and patient monitors in the western U.S.
  • In May 2016 U.S. FDA approved Medtronic’s Visia AF single-chamber implantable cardioverter defibrillators for tachycardia management

Global Defibrillator Market Summary

Study Period

2023-29

Base Year

2022

CAGR

3.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Defibrillators Market Dynamics

Defibrillator market growth is driven by rapidly growing geriatric patients who are very susceptible to cardiac diseases, technological advancements in defibrillators, growing awareness in sudden cardiac arrest, and increased incidents of cardiac diseases. Two of the most important advancements are development of automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). However, factors such as frequent product recalls, increase in pricing pressure on players, and lack of awareness about sudden cardiac arrest (SCA)

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Defibrillator Market Segmentation

By Product type
  • Implantable Cardioverter Defibrillators
    • Single Chamber Implantable Cardioverter Defibrillator
    • Dual Chamber Implantable Cardioverter Defibrillator
  • External Defibrillator
    • Manual
    • Automated
    • Wearable
By End User
  • Hospitals
  • Cardiac Clinics
  • Home Care

Frequently Asked Questions

The defibrillator market size was valued at USD 9.8 billion in 2022

The defibrillator market key players are: Medtronic (U.S.) Abbott Laboratories (U.S.) Asahi Kasei Corporation (ZOLL Medical Corporation) (Japan) LivaNova PLC (U.K) Physio-Control, Inc. (U.S.) Nihon Kohden Corporation (Japan) BIOTRONIK SE & Co. KG (Germany) Koninklijke Philips N.V. (Netherlands) Boston Scientific Corporation(U.S.)

The defibrillator market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1. Executive summary

2. Global Defibrillators Market Introduction

      2.1. Global Defibrillators Market– Taxonomy
      2.2. Global Defibrillators Market–Definitions
            2.2.1. End User
            2.2.2. Product Type
3. Global Defibrillators Market Dynamics
      3.1. Drivers
      3.2. Restraints
      3.3. Opportunities/Unmet Needs of the Market
      3.4. Trends
      3.5. Global Defibrillators Market Dynamics – Factors Impact Analysis
      3.6. Global Defibrillators Market– Recent Market Introductions
4. Global Defibrillators Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      4.3. Market Oppurtunity Analysis
5. Global Defibrillators Market Forecast, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029
      5.1. Implantable Cardioverter Defibrillators
            5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.1.3. Market Opportunity Analysis
      5.2. External Defibrillator
            5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.2.3. Market Opportunity Analysis
6. Global Defibrillators Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029
      6.1. Hospitals
            6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.1.3. Market Opportunity Analysis
      6.2. Cardiac Clinics
            6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.2.3. Market Opportunity Analysis
      6.3. Home Care
            6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.3.3. Market Opportunity Analysis
7. Global Defibrillators Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029
      7.1. North America
            7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.1.3. Market Opportunity Analysis
      7.2. Europe
            7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.2.3. Market Opportunity Analysis
      7.3. Asia-Pacific
            7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.3.3. Market Opportunity Analysis
      7.4. Latin America
            7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.4.3. Market Opportunity Analysis
      7.5. Middle East and Africa
            7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.5.3. Market Opportunity Analysis
      7.6. Global Defibrillators Market- Opportunity Analysis Index - By Product Type, By End User, and Region, 2023 - 2029
8. North America Defibrillators Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      8.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            8.1.1. Implantable Cardioverter Defibrillators
                        8.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
                        8.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
            8.1.2. External Defibrillator
                        8.1.2.1. Manual
                        8.1.2.2. Automated
                        8.1.2.3. Wearable
      8.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            8.2.1. Hospitals
            8.2.2. Cardiac Clinics
            8.2.3. Home Care
      8.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            8.3.1. U.S.
            8.3.2. Canada
      8.4. North America Defibrillators Market- Opportunity Analysis Index - By Product Type, By End User, and Country, 2023 - 2029
      8.5. North America Defibrillators Market Dynamics – Trends
9. Europe Defibrillators Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      9.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.1.1. Implantable Cardioverter Defibrillators
                        9.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
                        9.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
            9.1.2. External Defibrillator
                        9.1.2.1. Manual
                        9.1.2.2. Automated
                        9.1.2.3. Wearable
      9.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.2.1. Hospitals
            9.2.2. Cardiac Clinics
            9.2.3. Home Care
      9.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.3.1. Germany
            9.3.2. UK
            9.3.3. France
            9.3.4. Spain
            9.3.5. Italy
            9.3.6. Russia
            9.3.7. Poland
            9.3.8. Rest of Europe
      9.4. Europe Defibrillators Market- Opportunity Analysis Index - By Product Type, By End User, and Country, 2023 - 2029
      9.5. Europe Defibrillators Market Dynamics – Trends
10. Asia-Pacific Defibrillators Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      10.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            10.1.1. Implantable Cardioverter Defibrillators
                        10.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
                        10.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
            10.1.2. External Defibrillator
                        10.1.2.1. Manual
                        10.1.2.2. Automated
                        10.1.2.3. Wearable
      10.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            10.2.1. Hospitals
            10.2.2. Cardiac Clinics
            10.2.3. Home Care
      10.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            10.3.1. Japan
            10.3.2. China
            10.3.3. India
            10.3.4. ASEAN
            10.3.5. Australia & New Zealand
            10.3.6. Rest of Asia-Pacific
      10.4. Asia-Pacific Defibrillators Market- Opportunity Analysis Index - By Product Type, By End User, and Country, 2023 - 2029
      10.5. Asia-Pacific Defibrillators Market Dynamics – Trends
11. Latin America Defibrillators Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      11.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            11.1.1. Implantable Cardioverter Defibrillators
                        11.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
                        11.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
            11.1.2. External Defibrillator
                        11.1.2.1. Manual
                        11.1.2.2. Automated
                        11.1.2.3. Wearable
      11.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            11.2.1. Hospitals
            11.2.2. Cardiac Clinics
            11.2.3. Home Care
      11.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            11.3.1. Brazil
            11.3.2. Mexico
            11.3.3. Argentina
            11.3.4. Venezuela
            11.3.5. Rest of Latin America
      11.4. Latin America Defibrillators Market- Opportunity Analysis Index - By Product Type, End User, and Country, 2023 - 2029
      11.5. Latin America Defibrillators Market Dynamics – Trends
12. Middle East & Africa Defibrillators Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      12.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            12.1.1. Implantable Cardioverter Defibrillators
                        12.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
                        12.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
            12.1.2. External Defibrillator
                        12.1.2.1. Manual
                        12.1.2.2. Automated
                        12.1.2.3. Wearable
      12.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            12.2.1. Hospitals
            12.2.2. Cardiac Clinics
            12.2.3. Home Care
      12.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            12.3.1. Gulf Cooperation Council (GCC) Countries
            12.3.2. Israel
            12.3.3. South Africa
            12.3.4. Rest of MEA
      12.4. MEA Defibrillators Market- Opportunity Analysis Index - By Product Type, By End User, and Country, 2023 - 2029
      12.5. MEA Defibrillators Market Dynamics – Trends
13. Competition Landscape
      13.1. Strategic Dashboard of Top Market Players
      13.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
            13.2.1. Medtronic (U.S.)
            13.2.2. Abbott Laboratories (U.S.)
            13.2.3. Asahi Kasei Corporation (ZOLL Medical Corporation) (Japan)
            13.2.4. LivaNova PLC (U.K)
            13.2.5. Physio-Control, Inc. (U.S.)
            13.2.6. Nihon Kohden Corporation (Japan)
            13.2.7. BIOTRONIK SE & Co. KG (Germany)
            13.2.8. Koninklijke Philips N.V. (Netherlands)
            13.2.9. Boston Scientific Corporation(U.S.)
14. Research Methodology
15. Key Assumptions and Acronyms
  • Medtronic (U.S.)
  • Abbott Laboratories (U.S.)
  • Asahi Kasei Corporation (ZOLL Medical Corporation) (Japan)
  • LivaNova PLC (U.K)
  • Physio-Control, Inc. (U.S.)
  • Nihon Kohden Corporation (Japan)
  • BIOTRONIK SE & Co. KG (Germany)
  • Koninklijke Philips N.V. (Netherlands)
  • Boston Scientific Corporation(U.S.)